rs752247655

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP3BS2

The NM_000719.7(CACNA1C):​c.3424A>C​(p.Ile1142Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,613,742 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. I1142I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000035 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 missense

Scores

11
4
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 8.95

Publications

1 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.833
BS2
High AC in GnomAdExome4 at 51 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.3574A>C p.Ile1192Leu missense_variant Exon 28 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.3589A>C p.Ile1197Leu missense_variant Exon 28 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.3484A>C p.Ile1162Leu missense_variant Exon 28 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.3514A>C p.Ile1172Leu missense_variant Exon 27 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.3514A>C p.Ile1172Leu missense_variant Exon 27 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.3514A>C p.Ile1172Leu missense_variant Exon 27 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.3514A>C p.Ile1172Leu missense_variant Exon 27 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.3499A>C p.Ile1167Leu missense_variant Exon 28 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.3484A>C p.Ile1162Leu missense_variant Exon 28 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.3499A>C p.Ile1167Leu missense_variant Exon 28 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.3415A>C p.Ile1139Leu missense_variant Exon 27 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.3424A>C p.Ile1142Leu missense_variant Exon 27 of 46 ENSP00000507309.1 Q13936-19
CACNA1CENST00000480911.6 linkn.*2031A>C non_coding_transcript_exon_variant Exon 25 of 27 5 ENSP00000437936.2 F5H638
CACNA1CENST00000480911.6 linkn.*2031A>C 3_prime_UTR_variant Exon 25 of 27 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152168
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000120
AC:
3
AN:
250964
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000349
AC:
51
AN:
1461574
Hom.:
0
Cov.:
31
AF XY:
0.0000440
AC XY:
32
AN XY:
727124
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33478
American (AMR)
AF:
0.00
AC:
0
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86220
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000450
AC:
50
AN:
1111780
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152168
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41436
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000386
Hom.:
0
Bravo
AF:
0.0000264
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.00
EpiControl
AF:
0.0000594

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 24, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: CACNA1C c.3424A>C (p.Ile1142Leu) results in a conservative amino acid change located in the Ion transport domain (IPR005821) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 250964 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.3424A>C has been reported in the literature in one individual who may be affected by Arrhythmia (Adler_2016). The report does not provide unequivocal conclusions about association of the variant with Arrhythmia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -

not provided Uncertain:1
Jan 12, 2018
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The Ile1142Leu variant in the CACNA1C gene has not been reported previously as a disease-causing mutation nor as a benign polymorphism, to our knowledge. Although the Ile1142Leu results in a conservative substitution of one non-polar amino acid for another, the Ile1142 residue is conserved across species. In silico analysis predicts Ile1142Leu is possibly damaging to the proteins structure/function (Adzhubei I et al., 2010). The NHLBI ESP Exome Variant Server reports Ile1142Leu was not observed in approximately 5,000 samples from individuals of European and African American backgrounds, indicating it is not a common benign variant in these populations. However, Ile1142Leu occurs in a region of the CACNA1C gene with few reported mutations suggesting this region of the protein may tolerate change. With the clinical and molecular information available at this time, we cannot determine whether Ile1142Leu in the CACNA1C gene is a disease-causing mutation or benign variant. -

Long QT syndrome Uncertain:1
Oct 18, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CACNA1C protein function. ClinVar contains an entry for this variant (Variation ID: 190659). This missense change has been observed in individual(s) with an unspecified cardiac condition (PMID: 26743238). This variant is present in population databases (rs752247655, gnomAD 0.003%). This sequence change replaces isoleucine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1142 of the CACNA1C protein (p.Ile1142Leu). -

Cardiovascular phenotype Uncertain:1
Mar 21, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.I1142L variant (also known as c.3424A>C), located in coding exon 27 of the CACNA1C gene, results from an A to C substitution at nucleotide position 3424. The isoleucine at codon 1142 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. According to data from gnomAD, the frequency for this variant is above the maximum credible frequency for a cardiac disease-causing variant in this gene based on internally established thresholds (Karczewski et al.Nature. 2020 May;581(7809):434-443; Whiffin et al.Genet Med. 2017 10;19:1151-1158). Based on the supporting evidence, the association of this alteration withCACNA1C-related neurodevelopmental disorderis unknown; however, the association withCACNA1C-related Timothy syndrome or LQTS without extracardiac findingsis unlikely. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
CardioboostArm
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.27
D
BayesDel_noAF
Pathogenic
0.21
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.49
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.;.
Eigen
Pathogenic
0.70
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Pathogenic
0.98
D
M_CAP
Pathogenic
0.65
D
MetaRNN
Pathogenic
0.83
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.4
.;.;.;.;.;.;.;.;.;.;.;M;M;.;.;.;.;.;.;.;.;.;.;.
PhyloP100
8.9
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
-1.5
N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;.
REVEL
Pathogenic
0.85
Sift
Uncertain
0.0050
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;.
Sift4G
Benign
0.090
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;D
Polyphen
0.98, 0.65, 0.97, 0.92, 0.96, 0.98, 0.98, 0.53, 0.93
.;D;P;D;P;D;D;D;D;P;D;D;D;D;P;D;.;D;D;.;.;.;D;.
Vest4
0.72
MutPred
0.48
.;.;.;.;.;.;.;.;.;.;.;Gain of catalytic residue at S1163 (P = 0.0042);Gain of catalytic residue at S1163 (P = 0.0042);.;.;.;.;.;.;.;.;.;.;.;
MVP
0.88
MPC
2.1
ClinPred
0.87
D
GERP RS
4.7
gMVP
0.96
Mutation Taster
=10/90
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs752247655; hg19: chr12-2717744; API